The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Editas Medicine Inc’s current trading price is -66.24% away from its 52-week high, while its distance from the 52-week low is 130.74%. The stock’s price
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Editas Medicine Inc’s current trading price is -71.06% away from its 52-week high, while its distance from the 52-week low is 97.78%. The stock’s price
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Editas Medicine Inc’s current trading price is -69.94% away from its 52-week high, while its distance from the 52-week low is 105.47%. The stock’s price
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Editas Medicine Inc’s current trading price is -79.37% away from its 52-week high, while its distance from the 52-week low is 51.63%. The stock’s
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 29.92% since the start of this calendar year. Looking back over
Editas Medicine Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $6.69 on 05/15/24, with the lowest value being $0.91 on 04/07/25. 52-week price history of EDIT Stock Analyzing the 52-week price history of a stock,
In the biotechnology industry, tools for diagnosing health problems and mechanisms for treating them are developed. Biotech products typically require a significant amount of research and funding before they are approved by the FDA (Food and Drug Administration). A drug’s profitability is often discovered years
All rights reserved © 2024, Powered By Smart TechOne